A global biopharma is fighting malaria in endemic countries through partnerships that harness R&D, broaden access to ...

GSK's generous funding allows Save the Children to respond immediately ... including our biggest programs in the Democratic Republic of Congo, Ethiopia, Kenya, Nigeria and Yemen. Together, we are ...

The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...

GlaxoSmithKline has spent 20 years trying ... The trial was conducted in three countries where TB is endemic – Kenya, South Africa and Zambia – and involved 3,573 HIV-negative adults between ...

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

GSK and Pfizer said in the filing that they would dismiss the case with prejudice, which means it cannot be refiled. Spokespeople for the companies did not immediately respond to requests for ...

Big pharmaceutical companies have been making deals for technologies that could help them get their molecules through this protective membrane and now GSK is joining in, striking up an alliance ...

April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens new tab have agreed to end a lawsuit that alleged Pfizer's respiratory ...